BETHANECHOL Drug Patent Profile

Which patents cover Bethanechol, and what generic alternatives are available?

Bethanechol is a drug marketed by Able, Actavis Elizabeth, Amneal Pharm, Ascot, Chartwell Rx, Heritage Pharma, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lannett Co Inc, Sandoz, Sun Pharm Inds Inc, Upsher Smith Labs, Watson Labs, and Wockhardt. and is included in forty-four NDAs.

The generic ingredient in BETHANECHOL is bethanechol chloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Bethanechol

A generic version of BETHANECHOL was approved as bethanechol chloride by UPSHER SMITH LABS on June 1^st, 2005.

Summary for BETHANECHOL

US Patents:	0
Applicants:	15
NDAs:	44
Drug Prices:	Drug price information for BETHANECHOL
DailyMed Link:	BETHANECHOL at DailyMed

See drug prices for BETHANECHOL

US Patents and Regulatory Information for BETHANECHOL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Inc	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	040897-002	Apr 22, 2009		DISCN	No	No
Lannett Co Inc	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	040677-003	Mar 27, 2008		DISCN	No	No
Watson Labs	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	085230-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Wockhardt	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	040533-001	Sep 29, 2003		DISCN	No	No
Upsher Smith Labs	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	040634-001	Jun 1, 2005	AA	RX	No	No
Watson Labs	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	085841-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Watson Labs	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	085229-001	Approved Prior to Jan 1, 1982		DISCN	No	No